PATH
Menu

Filter browse results

Total results with these characteristics: 36

Subject: Vaccines and immunization > Malaria

Page 2 of 2
Malaria Vaccine Technology Roadmap

Scientists have been working for decades to develop a preventive malaria vaccine. While they have successfully demonstrated that such a vaccine is possible, many challenges continue to impede progress on the road to an effective malaria vaccine. As a result, the Malaria Vaccine Advisory Committee to the World Health Organization (WHO), coordinated by the WHO Initiative for Vaccine Research, called for a collective effort to explore and address the challenges. This effort resulted in the Malaria Vaccine Technology Roadmap process.

Publication date: August 2006

Region: Global

MVI Update

The PATH Malaria Vaccine Initiative (MVI) provides news and updates to collaborators and partners through MVI Update. Each issue opens with a letter from the director and provides articles about MVI’s work in malaria vaccine development and in preparing for vaccine availability and accessibility.

Publication date: 2014

Region: Global

Part of series: E-newsletters

The PATH Malaria Vaccine Initiative

The PATH Malaria Vaccine Initiative (MVI) is a vaccine development program of PATH. This fact sheet provides an overview of MVI's history, mission, vision, and work.

Publication date: November 2012

Region: Global

PATH Today (Fall 2001)

Publication date: September 2001

Region: Global

Part of series: PATH Today

PATH Today (Fall 2007)

This edition of PATH Today features the article "Preventing malaria and saving lives" and includes updates on PATH's AfriComNet award for magnet theater, the PATH Journeys donor travel program, the 2007 Breakfast for Global Health, and Global Impact. The issue also includes a profile of PATH donor Erick Rabins.

Publication date: September 2007

Region: Global

Part of series: PATH Today

PATH Today (Spring 2004)

Publication date: May 2004

Region: Global

Part of series: PATH Today

PATH Today (Spring 2013)

This issue of PATH Today describes PATH's multipronged approach to eliminating malaria in Africa and the development of semisynthetic artemisinin, a key ingredient in malaria treatment. It includes updates on PATH's work to prevent diarrhea in Cambodia and to diagnose cervical cancer. It also contains a profile of Dean Allen, CEO of McKinstry and PATH's board treasurer.

Publication date: May 2013

Region: Global

Part of series: PATH Today

PATH Today (Winter 2009)

This issue of PATH Today features a profile of PATH donor Miriam Sevy and her travels with PATH to Kenya, information about our work in Kenya, and an update on our new headquarters building in downtown Seattle. The issue also highlights Ultra Rice® winning the Tech Award, PATH's profile in a new book about the importance of individual donors, and the year-end matching challenge.

Publication date: December 2009

Region: Global

Part of series: PATH Today

PATH Today (Winter 2011)

This issue of PATH Today features our work in vaccines, with a focus on how PATH is making "hidden solutions" available, and describes lifesaving changes in South Africa's infant feeding policies. It also includes news from our malaria and meningitis work, an announcement of PATH's new blog, and a profile of PATH donor Lora Kaiser.

Publication date: December 2011

Region: Global

Part of series: PATH Today

PATH Today (Winter 2013)

This issue of PATH Today shares a breakthrough for a vaccine against Japanese encephalitis and the story of Dr. Nekoye Otsyula, a researcher on PATH's malaria vaccine trial. PATH donors Brian Arbogast and Valerie Tarico describe their approach to giving—supporting solutions that let people take care of themselves.

Publication date: December 2013

Region: Global

Part of series: PATH Today

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

This article, published in the New England Journal of Medicine (NEJM), reports results from a pivotal, large-scale Phase 3 trial of RTS,S/AS01 malaria vaccine. When compared to immunization with a control vaccine, infants (aged 6 to 12 weeks at first vaccination) vaccinated with RTS,S had one-third fewer episodes of both clinical and severe malaria and had similar reactions to the injection. In this trial, RTS,S demonstrated an acceptable safety and tolerability profile. The abstract of this article is available through the NEJM by clicking on "Visit web page" below, or for free access to the full lenth article please visit malariavaccine.org and click on "Read the NEJM article."

Publication date: December 2012

Region: Africa

Producing a Successful Malaria Vaccine: Innovation in the Lab and Beyond

Late-stage trials of an advanced malaria vaccine candidate—which, if approved, would become the world’s first malaria vaccine—are under way. This article, published in Health Affairs, recounts the pivotal roles played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine.

Author: Loucq C, Birkett A, Poland D, Botting C, Nunes J, Ethelston S

Publication date: June 2011

Region: Africa

Staying the Course? Malaria Research and Development in a Time of Economic Uncertainty

This report details malaria research and development funding from 2004 to 2009, including how much funding went to each product area, who provided the funding, and how investments flowed from funders to recipients. The report assesses progress against the Global Malaria Action Plan funding goals to identify what is needed in the next decade.

Publication date: June 2011

Region: Global

Strengthening National Regulatory Capacity: PATH Supports Countries to Ensure Health Products Are Safe, Effective, and Swiftly Delivered

Global investments to strengthen regulatory capacity in developing countries help ensure desperately needed medical products are delivered, thereby improving health and equipping countries with the expertise and infrastructure to make important health decisions for years to come.

Publication date: July 2012

Region: Global

Summary of Vaccine Stability Data

These documents provide stability data as of November 2012 on commonly used, licensed vaccines and stability data as of May 2012 from available data on novel, investigational vaccine formulations. Data are sorted by vaccine in a table format.

Publication date: November 2012

Region: Global

Vaccine Resource Library Website

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers a wide variety of high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. It is geared for health professionals in the developing and industrialized worlds, as well as for journalists, policymakers, community leaders, parents, and others interested in vaccine-related resources. The resources found on the VRL are collected from a variety of sources, including news media, scientific journals, and leaders in public health.

Publication date: 2014

Region: Global

Part of series: Websites

Page 2 of 2